Saltar al contenido
Merck
  • Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementation.

Dietary medium chain fatty acid supplementation leads to reduced VLDL lipolysis and uptake rates in comparison to linoleic acid supplementation.

PloS one (2014-07-23)
Daniël B van Schalkwijk, Wilrike J Pasman, Henk F J Hendriks, Elwin R Verheij, Carina M Rubingh, Kees van Bochove, Wouter H J Vaes, Martin Adiels, Andreas P Freidig, Albert A de Graaf
RESUMEN

Dietary medium chain fatty acids (MCFA) and linoleic acid follow different metabolic routes, and linoleic acid activates PPAR receptors. Both these mechanisms may modify lipoprotein and fatty acid metabolism after dietary intervention. Our objective was to investigate how dietary MCFA and linoleic acid supplementation and body fat distribution affect the fasting lipoprotein subclass profile, lipoprotein kinetics, and postprandial fatty acid kinetics. In a randomized double blind cross-over trial, 12 male subjects (age 51±7 years; BMI 28.5±0.8 kg/m2), were divided into 2 groups according to waist-hip ratio. They were supplemented with 60 grams/day MCFA (mainly C8:0, C10:0) or linoleic acid for three weeks, with a wash-out period of six weeks in between. Lipoprotein subclasses were measured using HPLC. Lipoprotein and fatty acid metabolism were studied using a combination of several stable isotope tracers. Lipoprotein and tracer data were analyzed using computational modeling. Lipoprotein subclass concentrations in the VLDL and LDL range were significantly higher after MCFA than after linoleic acid intervention. In addition, LDL subclass concentrations were higher in lower body obese individuals. Differences in VLDL metabolism were found to occur in lipoprotein lipolysis and uptake, not production; MCFAs were elongated intensively, in contrast to linoleic acid. Dietary MCFA supplementation led to a less favorable lipoprotein profile than linoleic acid supplementation. These differences were not due to elevated VLDL production, but rather to lower lipolysis and uptake rates.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Acetonitrilo, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Acetonitrilo, HPLC Plus, ≥99.9%
Sigma-Aldrich
Ácido fórmico, reagent grade, ≥95%
Sigma-Aldrich
Acetonitrilo, ACS reagent, ≥99.5%
Sigma-Aldrich
Ácido fórmico, ACS reagent, ≥96%
Sigma-Aldrich
Acetonitrilo, anhydrous, 99.8%
Sigma-Aldrich
Acetonitrilo, suitable for HPLC, gradient grade, ≥99.9%
Sigma-Aldrich
Ácido fórmico, ACS reagent, ≥88%
Sigma-Aldrich
Ácido octanoico, ≥99%
Sigma-Aldrich
Acetonitrilo, biotech. grade, ≥99.93%
Sigma-Aldrich
Acetonitrilo, electronic grade, 99.999% trace metals basis
Sigma-Aldrich
Ácido octanoico, ≥98%
Sigma-Aldrich
Ácido fórmico, ≥95%, FCC, FG
Sigma-Aldrich
Acetonitrilo, suitable for DNA synthesis, ≥99.9% (GC)
Supelco
Acetonitrilo, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Acetonitrilo, analytical standard
Sigma-Aldrich
Ácido octanoico, ≥98%, FG
Sigma-Aldrich
Ácido octanoico, natural, ≥98%, FG
Sigma-Aldrich
Acetonitrilo, ReagentPlus®, 99%
Supelco
Ácido octanoico, analytical standard
Supelco
Ácido octanoico, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Formic acid solution, BioUltra, 1.0 M in H2O
Leucine, European Pharmacopoeia (EP) Reference Standard
Ácido octanoico, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
DL-Leucine, ≥99% (HPLC)
USP
Acetonitrilo solution, United States Pharmacopeia (USP) Reference Standard
Supelco
Acetonitrilo, Pharmaceutical Secondary Standard; Certified Reference Material